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Introduction
============

In somatic cells, DNA damage or stalled DNA replication can activate the S-phase checkpoint, resulting in delayed cell cycle progression to allow the damage to be repaired (for reviews see [@bib2]; [@bib30]). S-phase checkpoint signaling is mediated by ataxia telangiectasia mutated and Rad3 related (ATR) and Chk1 protein kinases. Replication forks that stall at sites of DNA damage activate ATR, which then phosphorylates and activates Chk1. Finally, cell cycle progression is delayed by activated Chk1 through the modulation of core cell cycle regulators, such as the Cdc25 protein phosphatase.

In contrast to somatic cells, early embryonic cell cycles typically lack a checkpoint response to DNA damage (for review see [@bib26]). In both *Xenopus laevis* and *Drosophila melanogaster*, this is because an insufficient number of nuclei are present in early embryos, and, thus, an insufficiently robust checkpoint signal is generated to thwart the mitosis-promoting activity of maternally supplied and abundant Cdk1--cyclin B complexes. In both flies and frogs, it is only later in embryogenesis that the checkpoint signal produced by replication stress is strong enough to neutralize Cdk1--cyclin B, and this is caused by the accumulation of nuclei ([@bib7]; [@bib31], [@bib32]; [@bib34]; [@bib39]; [@bib5]; [@bib6]). In *Caenorhabditis elegans*, the situation is quite different. The ATR--Chk1 pathway is present and active from the first division onwards in worms, and it plays an important role in controlling the timing of cell division during the early cycles ([@bib3]). Checkpoint function is restricted to the P lineage, or future germ line, in *C. elegans* embryos, and its activation by as of yet undetermined developmental cues results in the delayed division of P cells relative to their sisters. This asynchrony in cell division is critical for embryonic and germ line development, as reducing the delay through inactivation of the ATR--Chk1 pathway results in germ line developmental failure and sterility, whereas extending the delay through hyperactivation of the ATR--Chk1 pathway results in patterning defects and embryonic lethality ([@bib10]; [@bib3]; [@bib19]; [@bib17]).

Although *C. elegans* differs from *Xenopus* and *Drosophila* in that the ATR--Chk1 pathway controls the pace of the early embryonic cycles, what is common between them is that like frog and fly embryos, the checkpoint is nonresponsive to DNA damage in early nematode embryos. This is not the result of insufficient signal strength but rather of the presence of an active silencing mechanism that suppresses the checkpoint response to DNA damage but allows the checkpoint to respond to developmental cues ([@bib17]). This silencing mechanism has presumably evolved to prevent unscheduled checkpoint activation, which would cause extended delays in cell division and, ultimately, embryonic lethality. Our laboratory identified this checkpoint silencing mechanism, and, to date, we have isolated three genes that are required for silencing: the *gei-17* SUMO E3 ligase, the *polh-1* translesion synthesis DNA polymerase, and the mutationally defined but uncloned *rad-2* gene ([@bib17]). Previous work has shown that *gei-17* and *polh-1* silence the checkpoint through their ability to promote the rapid replication of damaged DNA ([@bib17]), whereas the role of *rad-2* in silencing was as of yet unknown.

The *rad-2* mutation was isolated 25 yr ago in a screen for mutations causing embryonic sensitivity to DNA-damaging agents ([@bib14]). Follow-up phenotypic analysis of *rad-2* showed that mutant animals were competent for excision repair and that the period of DNA damage sensitivity was restricted to early embryogenesis ([@bib12]; [@bib15]; [@bib18]). More recently, we have shown that *rad-2* is a component of the silencing pathway that suppresses *chk-1* activation by DNA damage in early embryos ([@bib17]). This conclusion was based largely on effects of the *rad-2* mutation on the timing of cell division in early embryos exposed to DNA-damaging agents. Wild-type embryos did not delay the cell cycle after exposure to either methyl methanesulphonate (MMS) or UV-C or UV light, whereas *rad-2* mutant embryos showed a substantial delay. Importantly, the damage-induced delay in *rad-2* embryos was reversed upon the RNAi-mediated depletion of *chk-1*. These genetic experiments indicated that *rad-2* antagonizes the *chk-1* pathway during the early embryonic DNA damage response and prompted us to further explore *rad-2* function in checkpoint silencing.

In this study, we report the cloning of *rad-2* and show that the *rad-2* phenotype is caused by mutations in the *smk-1* gene. *smk-1* is an evolutionally conserved regulatory subunit of protein phosphatase 4 (PP4; or *pph-4.1* in *C. elegans*) and has recently been shown to control lifespan in the worm ([@bib37]). We report that the roles of *smk-1* in checkpoint silencing and longevity are distinct, and we show that the function of SMK-1 in silencing is to recruit PPH-4.1 to replicating chromatin so that it may antagonize checkpoint signaling during a DNA damage response. These results link PP4 to negative regulation of the ATR--Chk1 checkpoint, provide a targeting function for the SMK-1 regulatory subunit, and illustrate how during development primordial inputs into the ATR--Chk1 pathway such as DNA damage may be bypassed so that the checkpoint can respond exclusively to developmentally programmed inputs.

Results
=======

The *rad-2* mutation negatively affects CHK-1 activation during the DNA damage response
---------------------------------------------------------------------------------------

To gain cytological and biochemical evidence that *rad-2* antagonizes *chk-1* during a DNA damage response, we examined the phosphorylation status of CHK-1 in wild-type and *rad-2* embryos exposed to MMS. To do this, we used an antibody that recognizes the Ser345-phosphorylated (CHK-1--S345-P) and activated form of the enzyme and examined early embryos by immunofluorescence microscopy ([Fig. 1, A--L](#fig1){ref-type="fig"}).Figure 1.**Hyperactivation of CHK-1 by DNA damage in *rad-2* mutant embryos.** (A--L) Activated CHK-1 was detected by immunostaining with an antibody that recognizes the Ser345-phosphorylated CHK-1 (CHK-1(PO~4~-S345)). Embryos were counterstained with Hoechst 33258 to visualize the DNA. The images displayed are representative of a group of ≥10 embryos that were examined per sample. (M) Early embryo extracts were probed by immunoblotting with antibodies against CHK-1 (PO~4~-S345), unmodified CHK-1, and PCN-1. (N) Bar diagram summarizes quantitation of the CHK-1(PO~4~-S345) band intensity of three independent experiments after image densitometry analysis of the scanned images. +MMS refers to MMS exposure that was accomplished by culturing worms for 20 h on 0.05-mg/ml MMS plates. Error bars represent SD. Wild-type (N2) embryos displayed a punctate staining pattern with this antibody that was specific for the P lineage in both two-cell ([Fig. 1, A--C](#fig1){ref-type="fig"}) and four-cell ([Fig. 2 F](#fig2){ref-type="fig"}) embryos, and this signal was largely reduced in *chk-1* RNAi embryos (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200705182/DC1>).Figure 2.**Activated CHK-1 resides in P granules in both N2 and *rad-2* embryos.** The colocalization of activated CHK-1 with P granules in P cells of four-cell embryos was observed by coimmunostaining with antibodies against activated CHK-1 and the P granule component PGL-1 (OIC1D4). The images displayed are representative of a group of ≥10 embryos that were examined per sample. Exposure of N2 embryos to MMS did not substantially alter the CHK-1--S345-P signal intensity ([Fig. 1, D--F](#fig1){ref-type="fig"}), which is consistent with the checkpoint being silenced in wild-type embryos ([@bib17]). In contrast to wild type, however, *rad-2* embryos showed a noticeable increase in CHK-1--S345-P signal intensity after exposure to MMS ([Fig. 1, G--L](#fig1){ref-type="fig"}). To confirm these cytological observations biochemically, we prepared whole embryo extracts for the purpose of detecting activated CHK-1 by immunoblotting. As shown in [Fig. 1 M](#fig1){ref-type="fig"}, activated CHK-1 was not readily detected in control or MMS-exposed N2 embryos. In contrast, slightly more activated CHK-1 was observed in *rad-2* embryos, and this was substantially increased upon MMS exposure. To ensure equal loading, we also probed the blots for total CHK-1 and PCN-1, the worm orthologue of proliferating cell nuclear antigen, and found that equivalent amounts of these factors were present in all extracts. Image densitometry of the blot in [Fig. 1 M](#fig1){ref-type="fig"} revealed that approximately threefold more activated CHK-1 was present in *rad-2* embryos relative to wild type after exposure to MMS ([Fig. 1 N](#fig1){ref-type="fig"}). Based on the data in [Fig. 1](#fig1){ref-type="fig"}, we conclude that DNA damage activates CHK-1 to a greater extent in *rad-2* embryos relative to wild type.

The data in [Fig. 1 (A--L)](#fig1){ref-type="fig"} show that activated CHK-1 localizes to punctate cytoplasmic structures in P cells that are reminiscent of P granules. To determine directly whether these structures are indeed P granules, we performed colabeling experiments using antibodies against activated CHK-1 and the P granule component PGL-1 ([@bib20]). As shown in [Fig. 2 (A--D)](#fig2){ref-type="fig"}, the activated CHK-1 and PGL-1 signals overlapped, and, from this, we conclude that activated CHK-1 resides in P granules. To determine whether P granule residency was controlled by *rad-2*, we also stained early *rad-2* embryos with these antibodies and found that activated CHK-1 still resides in P granules despite the loss of *rad-2* function ([Fig. 2, E--H](#fig2){ref-type="fig"}). We conclude that activated CHK-1 localizes to cytoplasmic P granules in a *rad-2*--independent manner. The mechanism by which activated CHK-1 accumulates in P granules and the importance of this for CHK-1\'s ability to control the cell cycle is not yet known and is currently under investigation.

The *rad-2* mutation primarily affects early embryos during the DNA damage response
-----------------------------------------------------------------------------------

Having found that *rad-2* negatively regulates *chk-1* during the DNA damage response in early embryos, we next asked whether *rad-2* function was restricted to early embryogenesis or whether it was required throughout the embryonic period. Earlier studies had shown that plating *rad-2* embryos on media containing MMS did not prevent hatching, whereas exposing adults to MMS prevented the hatching of their progeny ([@bib14]; [@bib13]). This suggested that very early embryogenesis represented the period of DNA damage sensitivity in *rad-2* mutants; therefore, we sought a more direct test of this hypothesis. To do this, we collected early embryos from gravid adults by bleaching and plated these embryos. Next, we UV irradiated the embryos and determined survival as a function of both dose and time of administration of the UV light ([Fig. 3 A](#fig3){ref-type="fig"}).Figure 3.**The *rad-2* mutation primarily affects the early embryonic DNA damage response but not the checkpoint arrest in the germ line.** (A) 50 early embryos collected from gravid worms by bleaching were treated with UV light at the indicated times and doses and were scored for survival to determine embryonic lethality. The data shown were obtained from a representative experiment. See Table S1 (available at <http://www.jcb.org/cgi/content/full/jcb.200705182/DC1>) for the combined results of three trials with accompanying experimental error. (B) 10 UV light (100 J/m^2^)--irradiated hermaphrodites were crossed with eight undamaged males harboring a GFP-RNR transgene, and the viability of progeny was assessed. At least 500 eggs were examined per data point. See Materials and methods for experimental details. Error bars represent SD. (C) Gonads were dissected from wild-type N2 and *rad-2* hermaphrodites cultured in the absence (control) or presence (UV) of exposure to 100 J/m^2^ UV light and were fixed and stained with Hoechst 33258 to visualize the nuclei in the mitotic zone of the distal tip by fluorescence microscopy. The nuclei within a fixed volume were counted for a minimum of 10 samples per data point as described previously ([@bib17]). These counts ±SD are displayed below each image. Early *rad-2* embryos (i.e., those irradiated immediately after plating) were more sensitive to UV light than early wild-type embryos at all doses of UV that were tested. Interestingly, there was little difference in the UV light sensitivities of *rad-2* relative to wild type if the UV light was administered ≥4 h after plating ([Fig. 3 A](#fig3){ref-type="fig"}). From this, we conclude that early but not late embryos require *rad-2* to survive DNA damage.

In *C. elegans*, there are two sources of rapidly proliferating cells: the early embryo and the adult hermaphrodite gonad (for review see [@bib22]). We have previously shown that the *chk-1* pathway responds to DNA damage in the gonad but is silenced in the early embryo ([@bib17]). Therefore, it was of interest to determine whether *rad-2* function was restricted to early embryos or whether it was also required in the germ line to survive DNA damage. To do this, we UV light irradiated hermaphrodites to damage the germ cells and mated them to untreated males harboring a GFP--ribonucleotide reductase (RNR) transgene ([@bib40]). We then asked whether viable cross progeny could be produced from the UV-irradiated germ cells. We performed the mating step because we required a source of undamaged sperm so that all effects on the survival of progeny would be through DNA damage inflicted specifically in the mitotic zone of the hermaphrodite gonad. As shown in [Fig. 3 B](#fig3){ref-type="fig"}, the cross progeny from this experiment were viable, but the self progeny were not. This result indicates that mitotically dividing germ cells in the hermaphrodite gonad do not require *rad-2* function to survive DNA damage. The fact that the self progeny in this experiment were sensitive to DNA damage likely reflects the inability of early *rad-2* embryos to survive the damaged DNA supplied by the UV-irradiated sperm.

To pursue these observations further, we next asked whether the *rad-2* mutation hyperactivates the ATR--Chk1 pathway in the gonad, as it does in early embryos. Previous work has shown that mitotically dividing germ cells in the distal tip of the gonad arrest in an *atl-1*--dependent manner after exposure to UV light ([@bib17]). This arrest is reflected by a reduction in the number of nuclei at the distal tip (or mitotic zone) and an increase in their size. Therefore, we compared cell cycle arrest in wild-type versus *rad-2* gonads after exposure to UV light ([Fig. 3 C](#fig3){ref-type="fig"}). If the loss of *rad-2* function hyperstimulates the ATR--Chk1 pathway in germ cells, we would expect a more pronounced reduction in the number of mitotic nuclei at the distal tip in *rad-2* relative to wild-type gonads. We observed that UV light caused a reduction of 17.4 mitotic zone nuclei on average in wild-type animals and a reduction of 10.1 nuclei in *rad-2* gonads. These data show that the loss of *rad-2* function in distal tip germ cells does not reduce the number of UV light--exposed mitotic zone nuclei beyond what is observed in wild type and, in fact, that *rad-2* gonads are modestly more refractory to *atl-1*--dependent cell cycle arrest than are wild-type gonads. We conclude that the stimulatory effect of the *rad-2* mutation on the ATR--Chk1 pathway is specific for the early embryonic cell cycle.

*rad-2* corresponds to mutations in the *smk-1* gene
----------------------------------------------------

To pursue these observations further, we next sought to identify the gene encoding *rad-2*. Previous genetic analysis of *rad-2* had mapped the position of the gene to 1.09 ± 0.46 cM on chromosome V ([@bib14]). Using a combination of bulk segregation analysis, three-factor crosses, and single nucleotide polymorphism (SNP) mapping, we were able to refine this position to the interval between 1.38 and 1.88 cM. To identify *rad-2*, we performed an RNAi screen across this interval using the soaking method. We initially searched for genes that would render embryos sensitive to UV light after depletion by RNAi. This resulted in the identification of *smk-1* at position 1.49 cM as a candidate gene encoding *rad-2*. To pursue this further, we performed more detailed analysis of the *smk-1* RNAi phenotype. Two different regions of the gene, the central region and the 3′ end, were targeted for RNAi knockdown. RNAi against the central region (RNAi\#1) resulted in a low level of embryonic lethality, and this was greatly increased when embryos were exposed to MMS ([Table I](#tbl1){ref-type="table"}).Table I.Embryonic lethalityStrainConditionEmbryonic\
lethality*%*Wild-type N2−MMS0.9Wild-type N2+MMS7.8*rad-2(mn156)*−MMS0.8*rad-2(mn156)*+MMS90.0Wild-type N2/*smk-1* RNAi\#1−MMS4.5Wild-type N2/*smk-1* RNAi\#1+MMS91.3Wild-type N2/*smk-1* RNAi\#2−MMS70.5Wild-type N2/*smk-1* RNAi\#2+MMS100.0*rad-2(mn156)*/*smk-1* RNAi\#1−MMS27.3*rad-2(mn156)*/*smk-1* RNAi\#2−MMS90.0[^1] Therefore, RNAi\#1 phenocopies *rad-2*. RNAi against the 3′ end (RNAi\#2) resulted in high embryonic lethality even in the absence of MMS. When either RNAi\#1 or \#2 were combined with the *rad-2* mutation, embryonic lethality was higher than that observed in any single case alone ([Table I](#tbl1){ref-type="table"}). These results show that *smk-1* is an essential gene and that RNAi\#1 represents a hypomorphic condition. These results are also consistent with the idea that *rad-2* represents a hypomorphic allele of the *smk-1* gene.

A hallmark of the *rad-2* phenotype is that these embryos show a checkpoint-dependent delay in cell cycle progression in response to DNA damage. This is in contrast to wild-type embryos, which silence their checkpoint responses during a DNA damage response. If *rad-2* represents a hypomorphic allele of *smk-1*, *smk-1* RNAi\#1 should phenocopy *rad-2* for checkpoint silencing. To address this, we timed cell cycle progression in early embryos as described previously ([@bib17]). In both *rad-2* and *smk-1* RNA\#1 embryos, the first cell cycle occurred normally in the absence of DNA damage but was substantially delayed after exposure to MMS ([Fig. 4 A](#fig4){ref-type="fig"}).Figure 4.***rad-2* corresponds to mutations in the *smk-1* gene.** (A) The first embryonic cell cycle was timed in the indicated strains as described previously ([@bib17]). NEB, nuclear envelop breakdown; control, regular media; +MMS, media containing 0.05 mg/ml MMS. (B) Cartoon depicting the construct used to generate the *rad-2* (*pie-1--smk-1--*GFP) strain. The arrow and stop indicate the locations of the start and termination of translation, respectively. (C) Embryonic sensitivity to the indicated DNA-damaging agents was determined as described previously ([@bib17]). Error bars represent SD. Importantly, in both cases, this MMS-induced delay was reversed after *chk-1* RNAi. These results show that *smk-1* RNAi\#1 phenocopies the checkpoint silencing defect of *rad-2*. To determine whether a wild-type copy of the *smk-1* gene could rescue the *rad-2* phenotype, we made an *smk-1*--GFP fusion transgene ([Fig. 4 B](#fig4){ref-type="fig"}) driven by the *pie-1* promoter and introduced the gene into *rad-2* animals by particle bombardment to produce the *rad-2* (*pie-1*--*smk-1*--GFP) strain. Transformants were selected by virtue of GFP signals and were tested for sensitivity to DNA-damaging agents. Introduction of wild-type *smk-1* coding sequences into *rad-2* animals increased resistance to both MMS and UV light ([Fig. 4 C](#fig4){ref-type="fig"}). Furthermore, when the timing of cell division was examined in early embryos, we observed that *rad-2* (*pie-1*--*smk-1*--GFP) embryos did not delay the cell cycle to the same extent as *rad-2* mutants after exposure to MMS ([Fig. 4 A](#fig4){ref-type="fig"}). From this, we conclude that *smk-1* RNAi\#1 phenocopies the DNA damage response phenotypes of *rad-2* and that introduction of an *smk-1*--GFP transgene into *rad-2* mutants partially suppresses these phenotypes.

As further evidence that *rad-2* represents an allele of *smk-1*, we sought to link *rad-2* to a previously identified phenotype of *smk-1*, longevity. The *smk-1* gene was first identified in *C. elegans* as a regulator of lifespan ([@bib37]). RNAi against *smk-1* reduces both the lifespan of wild-type animals and the extended lifespan of *daf-2* mutant animals. Therefore, we performed longevity assays on *rad-2* animals and *rad-2* animals exposed to *daf-2* RNAi and compared these lifespans with N2 and N2 *daf-2* RNAi animals. As shown in [Table II](#tbl2){ref-type="table"}, in both cases, the N2 animals lived longer than *rad-2* animals.Table II.Lifespan of the *rad-2* mutantStrain/treatmentSurvivalP-values75th percentileAnimals died/total animalsWild-type N2/vector RNAi20.3 ± 0.47NA2389/100*rad-2(mn156)*/vector RNAi15.6 ± 0.52P \< 0.00011857/100Wild-type N2/*daf-2* RNAi38.9 ± 1.92P \< 0.0001[a](#tblfn1){ref-type="table-fn"}5590/100*rad-2(mn156)*/*daf-2* RNAi28.6 ± 1.97P \< 0.0001[a](#tblfn1){ref-type="table-fn"};\
P \< 0.0001[b](#tblfn2){ref-type="table-fn"}4041/100[^2][^3][^4] Thus, like *smk-1* RNAi, the *rad-2* allele reduces the lifespan of otherwise wild-type animals, and it reduces the extended lifespan that results from the depletion of *daf-2*.

To determine the molecular basis of the *rad-2* mutation, we sequenced the *smk-1* gene in the *rad-2* strain. *smk-1* encodes an evolutionally conserved regulatory subunit of PP4 ([@bib37]). Homologues of *rad-2* include human PP4R3, yeast *PSY2*, and *Drosophila falafel* ([@bib33]; [@bib38]; [@bib11]). Three differences were found in the *smk-1* gene from *rad-2* relative to wild-type strains (E497G, D580G, and D703G; [Fig. 5 A](#fig5){ref-type="fig"}).Figure 5.**Identification of mutations in the *smk-1* gene from the *rad-2* strain.** (A) Three mutations (E497G, D580G, and D703G) in genomic DNA sequences for the *smk-1* gene isolated from the *rad-2* strain were identified. (B) The aspartic acid residue at 703 is highly conserved from yeast to human (SMK-1, worm; PP4R3, human; flfl, fly; and Psy2, yeast). The gray shaded areas indicate similar and identical amino acids. (C) Recombinant myc-tagged SMK-1 or SMK-1 (D703G) was optionally mixed with recombinant untagged PPH-4.1, and the reactions were immunoprecipitated with anti-myc antibodies or nonspecific antibodies (IgG). Input, input material; IP, immunoprecipitated material. Of particular interest is the mutation occurring at position 703, as this aspartic acid residue is absolutely conserved from yeast to humans ([Fig. 5 B](#fig5){ref-type="fig"}) and is found within a highly conserved subdomain of the SMK-1 protein, conserved region 3 ([@bib37]). Collectively, our data show that *smk-1* RNAi phenocopies the *rad-2* allele for both DNA damage response and lifespan phenotypes, that a *smk-1* transgene can partially suppress the *rad-2* phenotype, and that the *smk-1* gene from the *rad-2* strain contains mutations, including an amino acid substitution at an evolutionally conserved position. We conclude that the *rad-2* phenotype is caused by mutations in the *smk-1* gene.

SMK-1 is a PPH-4.1--binding partner, and PPH-4.1 controls the early embryonic DNA damage response
-------------------------------------------------------------------------------------------------

Recent work has demonstrated that *smk-1* functions in lifespan regulation by controlling transcriptional activity of the *daf-16* forkhead box O (FOXO) transcription factor ([@bib37]). Thus, it was possible that the effects of *smk-1* on checkpoint silencing were through the regulation of *daf-16*. If so, we would expect that *daf-16* mutant embryos would be sensitive to DNA-damaging agents, but this was not the case ([Fig. 4 C](#fig4){ref-type="fig"}). These results show that although *rad-2* is an allele of *smk-1*, the role of *smk-1* in checkpoint silencing is distinct from its role in *daf-16*--mediated longevity.

In other organisms, *smk-1* orthologues form complexes with PP4 ([@bib11]). To see whether SMK-1 did the same, we performed coimmunoprecipitation experiments using proteins expressed by in vitro transcription/translation in rabbit reticulocyte lysate. Lysates expressing PPH-4.1, the *C. elegans* homologue of PP4, were mixed with lysates expressing epitope-tagged SMK-1. The mixtures were then immunoprecipitated with an antibody that recognizes the tag on SMK-1, and, as shown in [Fig. 5 C](#fig5){ref-type="fig"}, PPH-4.1 was found in these immune complexes. PPH-4.1 was not found in the immune complexes when epitope-tagged SMK-1 was omitted from the reaction or when nonspecific antibody was used in the coimmunoprecipitation, demonstrating specificity. We conclude that SMK-1 interacts with PPH-4.1. We next asked whether the D703G mutation in the *rad-2* allele of *smk-1*, which lies in conserved region 3 of the protein, influenced interaction between SMK-1 and PPH-4.1. As shown in [Fig. 5 C](#fig5){ref-type="fig"}, PPH-4.1 did not efficiently coimmunoprecipitate with a mutant form of SMK-1 containing the D703G substitution (SMK-1 D703G). These data suggest that at least in part, the *rad-2* phenotype is caused by a compromised interaction between SMK-1 and PPH-4.1.

To pursue these observations further, we assessed DNA damage response phenotypes for embryos depleted of *pph-4.1* by RNAi. Unlike *daf-16* mutants, embryos depleted of *pph-4.1* were very sensitive to both UV light and MMS ([Fig. 4 C](#fig4){ref-type="fig"}). Furthermore, *pph-4.1*--depleted embryos displayed a DNA damage--dependent delay in progression through the first cell cycle in a manner similar to *rad-2* embryos ([Fig. 4 A](#fig4){ref-type="fig"}). Based on these data, we conclude that the *rad-2* phenotype is caused by an inability of SMK-1 to control PPH-4.1 function during the DNA damage response.

SMK-1 is a chromosomal protein that recruits PPH-4.1 to replicating chromatin
-----------------------------------------------------------------------------

To learn more about how *smk-1* performs its checkpoint silencing function, we used the *rad-2* (*pie-1*--*smk-1*--GFP) strain to localize SMK-1--GFP in early embryos ([Fig. 6, A--L](#fig6){ref-type="fig"}).Figure 6.**SMK-1 is recruited to chromatin in a replication-dependent and checkpoint-independent manner.** (A--X) Either SMK-1--GFP (A--R) or histone H2B-GFP (S--X) was visualized in fixed samples using fluorescence microscopy. A--L and S--U are otherwise wild-type embryos, whereas M--O and V--X are *cdt-1* RNAi embryos, and P--R are *atl-1* RNAi embryos. The images displayed are representative of a group of ≥10 embryos that were examined per sample. The fusion protein was nuclear throughout all stages of the cell cycle. At prophase, SMK-1--GFP colocalized with condensed chromosomes, indicating that SMK-1 is a chromosomal protein ([Fig. 6, D--I](#fig6){ref-type="fig"}). To make certain that these localization patterns were not an artifact of the exogenous *pie-1* promoter used in our construct, we repeated this analysis with a strain driving SMK-1--GFP off the endogenous *smk-1* promoter and obtained identical results (unpublished data). To see whether chromosomal occupancy of SMK-1 was dependent on DNA replication, we treated *rad-2* (*pie-1*--*smk-1*--GFP) animals with RNAi against the replication initiation factor *cdt-1*. As shown in [Fig. 6 (M--O)](#fig6){ref-type="fig"}, the chromosomal localization of SMK-1--GFP was abolished in *cdt-1* RNAi embryos. This was not the case for embryos expressing a histone H2B-GFP fusion protein, which localized to condensed chromatin regardless of the depletion of *cdt-1* ([Fig. 6, S--X](#fig6){ref-type="fig"}). We also asked whether abrogation of the ATR pathway influenced the chromosomal localization of SMK-1 and found that SMK-1 localization was not perturbed by *atl-1* RNAi ([Fig. 6, P--R](#fig6){ref-type="fig"}). The effectiveness of the *atl-1* RNAi in this experiment was ascertained by the high level of embryonic lethality that resulted, which is a known consequence of *atl-1* RNAi ([@bib1]). From this experiment, we conclude that SMK-1 is recruited to chromatin in a replication-dependent and checkpoint-independent manner.

The results obtained thus far indicate that SMK-1 and PPH-4.1 form a complex, that both proteins confer DNA damage resistance to early embryos, and that SMK-1 is recruited to chromatin in early embryos in a manner dependent on DNA replication. To pursue the chromatin-binding properties of SMK-1 further, we developed a chromatin-binding assay for early embryos ([Fig. 7 A](#fig7){ref-type="fig"}) based on previously published procedures ([@bib28]).Figure 7.**SMK-1 recruits PPH-4.1 to replicating chromatin.** (A) A chromatin association assay for early embryos was developed, and the procedure is depicted. The gel shows an immunoblot for α-tubulin, PCN-1, SMK-1--GFP, or PPH-4.1 from the indicated fractions. See Results and Materials and methods for details on the relevant fractions. The tubulin and PCN-1 samples were taken from N2 embryos, and the SMK-1--GFP and PPH-4.1 samples were taken from *rad-2* (*pie-1*--*smk-1*--GFP) embryos. (B) An immunoblot of either whole embryo extract (WEE) or the chromatin protein--containing fraction C from embryos of the given strain. Animals were cultured in the absence (−) and presence (+) of 0.05 mg/ml MMS, and the blots were probed with anti-GFP antibodies to visualize SMK-1--GFP or anti--PCN-1 antibodies. (C) Same as B except the blots were probed with antibodies recognizing PPH-4.1 or PCN-1. +MMS indicates MMS exposures that were accomplished by culturing worms for 20 h on 0.05-mg/ml MMS plates. Large quantities of early embryos were isolated from adults and sonicated to produce an embryo extract. The extract was centrifuged to produce two fractions: a supernatant (A) and the chromatin-containing pellet (B). The pellet fraction was then treated with micrococcal nuclease to degrade the DNA and to release the DNA-bound chromatin proteins. This reaction was then centrifuged again to produce a supernatant (C) and pellet (D) fractions. Proteins that were originally in the first pellet fraction (B) but were found in the second supernatant fraction (C) after micrococcal nuclease treatment were defined as chromatin proteins and identified by immunoblotting. As shown in [Fig. 7 A](#fig7){ref-type="fig"}, the known chromatin protein PCN-1 was found in fractions B and C but not in fraction D as expected. In contrast, the nonchromatin protein tubulin was found exclusively in fraction A, verifying that this procedure can identify chromatin proteins. We also examined the behavior of SMK-1--GFP and PPH-4.1 under these fractionation conditions. As expected, based on the localization data in [Fig. 6](#fig6){ref-type="fig"}, SMK-1--GFP was found in the chromatin protein--containing fraction C. PPH-4.1 was also found in fraction C, and some was observed in fraction D. It may be that a subset of PPH-4.1 associates with a nonchromosomal, easily sedimenting structure such as the centrosome ([@bib35]).

We next used this assay to monitor the chromatin association of SMK-1--GFP and PPH-4.1 under different conditions. As shown in [Fig. 7 B](#fig7){ref-type="fig"}, SMK-1--GFP was found in the chromatin protein--containing C fraction in both control and MMS- exposed embryos (lanes 2 and 3). RNAi-mediated depletion of *gei-17*, another checkpoint silencing gene, had no effect on the chromatin binding of SMK-1--GFP ([Fig. 7 B](#fig7){ref-type="fig"}, lanes 4 and 5), whereas RNAi against *smk-1* itself did prevent the recovery of SMK-1--GFP in the chromatin fraction ([Fig. 7 B](#fig7){ref-type="fig"}, lane 6) as expected. PCN-1 was used as a control for these experiments and was found in the chromatin fraction under all conditions. To pursue these observations further, we extended this analysis to PPH-4.1. The PPH-4.1 protein was found in the chromatin fraction of both control and MMS-exposed wild-type embryos ([Fig. 7 C](#fig7){ref-type="fig"}, lanes 1 and 2). Importantly, the amount of PPH-4.1 that associated with chromatin in *rad-2* embryos was noticeably reduced relative to wild-type embryos ([Fig. 7 C](#fig7){ref-type="fig"}, lanes 3 and 4). The overall level of PPH-4.1 in *rad-2* versus wild-type extracts was only modestly reduced. To confirm these data using an alternative method, we immunostained MMS-exposed wild-type and *rad-2* embryos with antiserum directed against PPH-4.1. As shown in Fig. S2 (available at <http://www.jcb.org/cgi/content/full/jcb.200705182/DC1>), the PPH-4.1 signal was nuclear in wild-type embryos but not in *rad-2* embryos. Based on these results, we conclude that SMK-1 functions to recruit the PPH-4.1 phosphatase to chromatin and that a failure to do so, such as in *rad-2* embryos, leads to hyperactivation of the *chk-1* response to DNA damage and subsequent embryonic lethality.

Discussion
==========

In this study, we have shown that mutations in the *smk-1* gene cause the *rad-2* phenotype. We have also shown that although the *rad-2* mutation has a strong effect on early embryonic DNA damage resistance, it does not affect damage resistance in proliferating cells of the germ line. Consistent with a role for *smk-1* in early embryos but not the germ line is published data showing that an SMK-1--GFP fusion protein expressed off the endogenous *smk-1* promoter is abundant in early embryos as well as other tissues of the worm but is not readily observed in the germ line ([@bib37]). Therefore, it may be that the embryonic specificity of the checkpoint silencing pathway is achieved through preferential expression of the SMK-1--PPH-4.1 complex in embryos relative to germ cells. The lack of a *rad-2* phenotype in germ cells must be interpreted with caution, however, given the hypomorphic nature of the *rad-2* allele.

The work presented here has uncovered a role for SMK-1 in silencing DNA damage--based CHK-1 activation in early embryos. In *C. elegans*, SMK-1 also functions in the insulin-mediated control of longevity ([@bib37]). In longevity, SMK-1 modulates the activity of the DAF-16 transcription factor through an unknown mechanism to regulate the expression of DAF-16 target genes. We have shown here that DAF-16 is not required for checkpoint silencing, and, thus, it appears that the roles for SMK-1 in aging and checkpoint silencing are distinct. DAF-16 is a member of the FOXO superfamily of transcriptional regulators, and, therefore, it is possible that SMK-1 functions with a FOXO transcription factor that is distinct from DAF-16 in the checkpoint silencing pathway. We do not favor this hypothesis, however, as it is generally true that early embryonic cell cycle control is driven by maternally supplied regulators and not via zygotic transcription. Although the roles of *smk-1* in longevity and checkpoint silencing can be unlinked in the embryo, we note that *chk-1*, the *smk-1* target for silencing, has been shown to reduce lifespan in the worm by acting in postmitotic cells ([@bib27]). Therefore, it may be that *smk-1* antagonizes the *chk-1* effect on lifespan, and experiments are in progress to test this hypothesis.

SMK-1 is an evolutionally conserved regulatory subunit of the PP4 phosphatase. Links between the PP4 complex and DNA damage response have been uncovered before, although not in the context of regulation of the ATR--Chk1 pathway as has been reported here. In *Drosophila*, loss of the SMK-1 orthologue *falafel* causes sensitivity to the DNA-damaging agent cisplatin ([@bib11]). In yeast, the SMK-1 orthologue Psy2 and the PP4 orthologue Pph3 have been shown to control the phosphorylation status of the histone variant H2AX after DNA damage ([@bib21]). In this case, dephosphorylation of H2AX by Pph3 is required for attenuation of the checkpoint response to double-strand breaks. This is somewhat similar to the results reported here, in which SMK-1 and PPH-4.1 negatively regulate the ATR--Chk1 pathway after DNA damage; however, the mechanism in *C. elegans* is clearly different, as worms do not have H2AX. Although these previous reports clearly linked SMK-1 orthologues to the DNA damage response ([@bib11]; [@bib21]), they did not explain the role of SMK-1 in this process. We report here that SMK-1 is a chromosomal protein and that its recruitment to chromatin is dependent on ongoing DNA replication. Furthermore, we show that SMK-1 is required to recruit PPH-4.1 to chromatin, the site of CHK-1 activation during a DNA damage response. Collectively, these data supply a function for SMK-1 during the DNA damage response (the targeting of PPH-4.1 to chromatin) and suggest that the SMK-1--PPH-4.1 complex may be a general regulator of the ATR--Chk1 pathway in metazoan cells.

Although our data clearly identify SMK-1--PPH-4.1 as an important negative regulator of the checkpoint response to DNA damage in early nematode embryos, we do not at present know the critical target for this phosphatase complex in attenuating the checkpoint response. Chk1 is known to be regulated directly by protein phosphatase 2A ([@bib23]), by PPM1D, a type 2C phosphatase ([@bib24]), and by Dis2, a type I phosphatase in fission yeast ([@bib8]). Preliminary results from our laboratory have shown that PPH-4.1 and CHK-1 form a complex (unpublished data), and, thus, it may be that PP4-type phosphatases are also capable of the direct regulation of Chk1. Regulation of Chk1 is likely to be complex in any given cell type, and is likely to involve multiple phosphatases controlling Chk1 under different circumstances and in different subcellular locations. Our data show that a site for regulation of the ATR--Chk1 pathway by PP4 is chromatin, and this is consistent with the embryo\'s requirement that the Chk1 pathway be rapidly inactivated so as to prevent potentially lethal delays in cell cycle progression. To completely understand how the checkpoint is silenced in early embryos, it will be necessary to identify the SMK-1--PPH-4.1 target and to determine how this target is accessed by SMK-1--PPH-4.1 on replicating DNA.

Materials and methods
=====================

*C. elegans* strains
--------------------

The wild-type N2 Bristol strain was used in all control experiments ([@bib4]). SP488 (*rad-2\[mn156\]*), CF1038 (*daf-16\[mu86\]*), and AZ212 (*unc-119(ed3) ruIs32\[unc-119(*+*) pie-1--GFP--H2B\]*) strains were provided by T. Stiernagle (*Caenorhabditis* Genetics Center, University of Minnesota, Minneapolis, MN). An RNR-GFP strain (*maIs*103*\[unc-36(*+*), rnr--GFP\]*) was provided by E. Kipreos (University of Georgia, Athens, GA; [@bib40]).

Genetic mapping of the *rad-2* locus
------------------------------------

Previous genetic mapping had determined the chromosome location of *rad-2* to be V:1.09 ± 0.461 cM ([@bib14]). To confirm and extend these initial mapping data, the TH37 strain containing *dpy-11* and *unc-23* markers located at V:0.00 cM and V:1.88 cM, respectively, was used in three-factor cross mapping of *rad-2*. TH37 hermaphrodites (*dpy-11*−*/rad-2*+*/unc-23*−) were mated with *rad-2* males (*dpy-11*+*/rad-2*−*/unc-23*), and cross progeny were isolated. These worms were allowed to self-fertilize, and recombinants representing the *dpy-11*−*/unc-23*+ and *dpy-11*+*/unc-23*− genotype were identified. Once it has been determined that recombinant worms were homozygous for each marker, the status of the *rad-2* gene was determined for each recombinant. 27 *dpy-11*−*/unc-23*+ and 21 *dpy-11*+*/unc-23*− homozygous recombinants were screened for MMS sensitivity. The fact that *dpy-11*−*/rad-2*− and *rad-2*−*/unc-23*− recombinants were isolated confirms that *rad-2* is to the right of *dpy-11* and to the left of *unc-23*, or between 0.00 and 1.88 cM. In a total of 48 recombination events, 30 events occurred between *dpy-11* and *rad-2*, and 18 events occurred between *rad-2* and *unc-23*. These numbers translated to map ratios of 0.625 and 0.375 for *dpy-11* and *unc-23*, respectively. Therefore, the three-factor cross indicated that *rad-2* lies closer to *unc-23* at V:1.175 with a 95% confidence interval of ±0.273 cM.

To further narrow the region of the *rad-2* gene, we performed SNP mapping. *dpy-11*−*/rad-2* worms were mated to the Hawaiian CB4856 strain, and five recombinants that were *dpy-11* and wild type for *rad-2* (based on MMS sensitivity) were isolated. SNPs located between 1.14 and 1.46 cM were PCR amplified from recombinant worm lysates, and the origin of DNA at each locus was determined by either snip-SNP analysis or sequencing of the SNP. This analysis revealed that among the recombinants, *rad-2* DNA could be found at positions 1.14, 1.27, and 1.38 cM but not at 1.46 cM. This analysis positioned the *rad-2* locus to the right of 1.38 cM and, in combination with the three-factor crosses, defined the interval between 1.38 and 1.88 cM as the location of the *rad-2* gene.

RNAi
----

*smk-1* and *pph-4.1* RNAi by soaking method was performed as described previously ([@bib25]). *smk-1*, *gei-17*, *daf-2*, *cdt-1*, and *atl-1* RNAi by feeding method was performed as described previously ([@bib36]), and *chk-1* RNAi was performed as described previously ([@bib17]).

UV sensitivity assays
---------------------

To examine whether *rad-2* function was restricted to early embryogenesis or whether it was required throughout the embryonic period, UV sensitivity assay was performed using embryos prepared by bleaching N2 and *rad-2* gravid hermaphrodites on the basis of published protocols ([@bib9]). About 50 early embryos were plated on fresh plates and exposed to UV light at 0, 10, and 25 J/m^2^ at the indicated times in [Fig. 3 A](#fig3){ref-type="fig"}. 24 h after UV irradiation, the unhatched eggs were counted. Embryonic lethality was determined by dividing the number of eggs remaining after 24 h by the total number plated.

To examine whether *rad-2* function was restricted to early embryos or whether it was also required in the germ line to survive DNA damage, UV light--irradiated hermaphrodites were crossed with untreated male worms harboring an RNR-GFP transgene, and the UV light sensitivity of progeny was examined. To do this, 10 L4-stage N2 and *rad-2* hermaphrodites were exposed to 100 J/m^2^ UV light followed by plating eight males harboring an RNR-GFP transgene. 48 h after transferring males, all worms were removed from the plate, and GFP and non-GFP embryos were counted. After 24 h, the embryos were scored for survival to determine embryonic lethality.

Cloning of the *rad-2* gene and lifespan analysis
-------------------------------------------------

Using a combination of bulk segregation analysis, three-factor crosses, and SNP mapping, the position of the *rad-2* gene was refined to the genetic interval between 1.38 and 1.88 cM. To clone the *rad-2* gene, UV-sensitive genes across this genetic interval were initially identified by UV sensitivity assay after depletion by soaking RNAi and were analyzed further by MMS sensitivity assay and timing of cell division in living embryos, which were performed as described previously ([@bib17]). For longevity assay of *rad-2*, lifespan and statistical analyses were performed as described previously ([@bib37]).

Rescue of *rad-2* mutant and genomic DNA sequencing
---------------------------------------------------

To construct an *smk-1*--GFP fusion transgene, a full-length cDNA of the *smk-1* gene was cloned into a *pie-1*--GFP germline expression vector ([@bib29]). The *smk-1*--GFP fusion transgene was introduced into the *rad-2* mutant by microparticle bombardment to generate the *rad-2* (*pie-1--smk-1--*GFP) strain. Using this transgenic strain, rescue of the *rad-2* mutant was assessed by restoring normal embryonic viability and timing of cell division in living embryos in response to UV light and MMS exposures. Additionally, we also monitored the behavior of SMK-1--GFP expressed under the control of an endogenous *smk-1* promoter in early embryos of a transgenic strain, *smk-1p--smk-1--GFP*, which were generated previously ([@bib37]). For genomic DNA sequencing, genomic DNA corresponding to the *smk-1* gene was isolated from the *rad-2* mutant and cloned into pCR2.1-TOPO vector (Invitrogen). Mutations in the genomic DNA were identified by DNA sequencing performed by Agencourt Bioscience Corp.

Antibodies, whole embryo extracts, and immunoblotting
-----------------------------------------------------

*C. elegans* proliferating cell nuclear antigen orthologue PCN-1 antibody was generated by immunizing rabbits with the peptide DIDSEHLGIPDQDYAVVCE (Bethyl Laboratories). *C. elegans* PP4 orthologue PPH-4.1 antibody was a gift from M. Yamamoto (University of Tokyo, Tokyo, Japan; [@bib35]). Antibodies against phospho-Chk1 Ser345 (Cell Signaling Technology), Chk1 (Santa Cruz Biotechnology, Inc.), GFP (Abcam), OIC1D4 (Developmental Studies Hybridoma Bank), α-tubulin (Sigma-Aldrich), and c-myc (Santa Cruz Biotechnology, Inc.) were purchased. To prepare whole embryo extracts, embryos were obtained by bleaching gravid hermaphrodites and were suspended in twice the pellet volume of homogenization buffer (50 mM Hepes, pH 7.6, 200 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.2% Triton X-100, 5% glycerol, and protease inhibitors). The embryo suspension was sonicated and clarified by centrifugation at 12,000 *g* at 4°C for 30 min. The pellet was resuspended in half the pellet volume of homogenization buffer. Immunoblotting was performed by the standard procedures with HRP-conjugated mouse or rabbit secondary antibodies (GE Healthcare), and protein bands were detected by enhanced chemiluminescence (Pierce Chemical Co.).

Chromatin protein fractions and chromatin-binding assay
-------------------------------------------------------

To prepare embryo extract fractions containing chromatin proteins, large quantities of embryos were obtained by bleaching gravid hermaphrodites and were suspended in twice the pellet volume of homogenization buffer. The embryo suspension was sonicated briefly on ice until the mixture had lost its viscosity. The sonicated embryo mixture was clarified by centrifugation at 8,000 *g* at 4°C for 5 min, and the pellet was resuspended in half the pellet volume of homogenization buffer. The chromatin proteins were extracted from the pellet by adding micrococcal nuclease (Roche Applied Science) followed by centrifugation at 15,000 *g* for 20 min at 4°C. The supernatant fraction containing chromatin proteins was identified by immunoblotting with antibodies against α-tubulin and PCN-1, which are nonchromatin and chromatin proteins, respectively.

Site-directed mutagenesis, in vitro transcription and translation, and coimmunoprecipitation
--------------------------------------------------------------------------------------------

The full-length cDNAs of *smk-1* and *pph-4.1* genes were cloned into pCS2+MT vector containing myc epitope tags and pSP72 vector, respectively. The myc-tagged SMK-1 mutant displacing an aspartic acid residue at position 703 to a glycine (myc-SMK-1 \[D703G\]) was generated by the Quik-Change II Site-Directed Mutagenesis kit (Stratagene). The myc--SMK-1, myc--SMK-1 (D703G), and untagged PPH-4.1 were transcribed and translated (T~N~T reaction) in the presence of \[^35^S\]methionine according to the manufacturer\'s instructions (Promega). For coimmunoprecipitation, 10 μl T~N~T reactions were mixed in 400 μl of binding buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 5 mM MgCl~2~, 10% glycerol, and 0.1% NP-40) and incubated with 0.5 μg of anti--mouse myc antibody at 4°C for 4 h. A mouse IgG (Santa Cruz Biotechnology, Inc.) was used as a nonspecific antibody for demonstrating specificity. After an overnight incubation with 20 μl of protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Inc.) at 4°C, immunoprecipitated beads were washed three times with binding buffer. The protein bound to the beads was eluted by boiling in 30 μl of 2× Laemmli sample buffer. The samples were run on SDS-polyacrylamide gels and detected by autoradiography.

DNA staining, immunostaining, and fluorescence microscopy
---------------------------------------------------------

Embryos and gonads were dissected form adult hermaphrodites and were fixed and stained by Hoechst 33258 as described previously ([@bib16], [@bib17]). The images of nuclei in the gonad ([Fig. 3 C](#fig3){ref-type="fig"}) were captured on camera (2.1.1; Diagnostic Instruments) and processed using SPOT Advanced version 3.2.4 software (Diagnostic Instruments). UPlanAPO 40× NA 1.40 oil objective lenses were used. The nuclei in the mitotic zone of the gonad were then counted as described previously ([@bib17]). For immunostaining, the fixed embryos were incubated with antibodies against phospho-Chk1 (Ser345), OIC1D4, and PPH-4.1 overnight at 4°C followed by a 2-h incubation with FITC- or rhodamine-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories). All confocal images ([Figs. 1, A--J](#fig1){ref-type="fig"}; [2, A--H](#fig2){ref-type="fig"}; [6, A--X](#fig6){ref-type="fig"}; S1, A--F; and S2, A--I) were obtained by a confocal system (LSM510 META; Carl Zeiss MicroImaging, Inc.) attached to a laser-scanning microscope (Axiovert 100M; Carl Zeiss MicroImaging, Inc.). Plan-Neofluar 40× NA 1.30 oil objective lenses (Carl Zeiss MicroImaging, Inc.) were used. All microscopic experiments were performed at room temperature.

Online supplemental material
----------------------------

Fig. S1 shows that the activated CHK-1 signal is largely reduced in *chk-1* RNAi embryos. Fig. S2 shows that the nuclear localization of PPH-4.1 is abolished in MMS-exposed *rad-2* and *pph-4.1* RNAi embryos. Table S1 shows the embryonic lethality in Fig. 3 A. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200705182>.
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[^1]: Embryonic lethality was determined by dividing the number of eggs remaining after 24 h by the total number plated on 0.05-mg/ml MMS plates. At least 500 eggs were examined per data point. MMS exposure was accomplished by culturing worms for 20 h on MMS plates.

[^2]: Survival is given as the mean days ± SEM. The last column provides the total number of animals that died/total animals. NA, not applicable.

[^3]: Compared with wild-type N2 worms on vector RNAi.

[^4]: Compared with wild-type N2 worms on the same RNAi treatment.
